Secondary analysis of 508 patients in the RELIEVE-HF trial of interatrial shunt vs placebo procedure: risk modelling estimated 67.2% of patients with HFrEF might benefit from the shunt, compared with 21.4% of those with HFpEF, with distinct predictors in each group.
Secondary analysisn = 508
Stone et al. Modeling Individual Patient Outcomes After Interatrial Shunt Treatment in Heart Failure With Reduced and Preserved Ejection Fraction: The RELIEVE-HF Trial